High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with Depression
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with Depression
批准号:
9352370
负责人:
HOWARD J AIZENSTEIN
金额:
$60.02万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-13 至 2021-06-30
关键词:
AddressAffectAlzheimer&aposs DiseaseAmericanAreaAutopsyBlood VesselsBrainCerebral small vessel diseaseCharacteristicsClinicalClinical ResearchCognitiveCollaborationsConsultationsCustomDataDetectionDevelopmentDiffusionDiseaseDisease MarkerDisease ProgressionDisease modelEdemaElderlyEvaluationGliosisGoalsGrowthGuidelinesHeadHeatingHistopathologyHumanImageImage AnalysisIndividualInflammationIschemiaLesionLettersLife ExpectancyMachine LearningMagnetic Resonance ImagingMainstreamingMedicareMental DepressionMethodologyMicrovascular DysfunctionMinnesotaModelingMorbidity - disease rateNoiseParticipantPatientsPerformancePerfusionPhysiologic pulsePopulationPopulation StudyPrevention strategyProcessProtocols documentationRecruitment ActivityResearchResolutionRoleSafetyScanningSignal TransductionSpecificityStatistical ModelsSyndromeSystemTarget PopulationsTechnologyTestingTimeUniversitiesWhite Matter HyperintensityWorkabsorptionaging brainbaseclinically relevantcohortcostdesigndisturbance in affectfollow-upgeriatric depressionimaging approachimprovedin vivoinnovationinterestmagnetic fieldmortalityneuropathologynovelradiofrequencytheoriestooltransmission processtreatment strategyvascular depression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Depression (target disease of this proposal) affects 34 million Americans including 2 million seniors per year. It
is a leading cause of morbidity and mortality in older adults (target population of this proposal). The vascular
depression hypothesis (proposed in 1998) remains the most salient theory explaining the onset and
perpetuation of depression in older adults. This model is based on the observation that in older adults, white
matter hyperintensities (a hallmark of small vessel disease, SVD) are associated with depression onset and
perpetuation. Progress in understanding the relationship of small vessel disease with late-life depression has
been stymied in part by lack of specificity of white matter hyperintensities which can represent components of
edema, gliosis, ischemia, and inflammation. Traditional MR imaging is unable to distinguish between these
components, and thus the specific mechanisms that contribute to depression remain unclear.
The emergence of ultrahigh field MR imaging allows for greater specificity of the WMH lesions, and
other components of small vessel disease. Bringing 7 tesla (T) imaging into mainstream clinical use will be
accomplished through 1) having exclusive (over 1.5/3T) application(s) and 2) achieving robust, safe,
consistent, and homogenous high-quality images. Through a consortium consisting of experts at University of
Pittsburgh combined with collaboration at FDA, University of Minnesota, and Quality Electrodynamics Inc., our
goal is to enhance our understanding of the neuropathophysiology, treatment, and management of depression
in older adults. We will achieve this goal through the development of robust radiofrequency methodology, as
well as pulse sequences that produce 7T images with the aforementioned necessary attributes. This will be
paired with complementary 3T MRI at baseline. We will use our recently developed (as well as a proposed)
custom designed 7T radiofrequency coil system and pulse sequences that are already being used in
disease/patient studies. Based on our preliminary results, the proposed RF solution will provide
unprecedented homogeneity and consistency among different subjects/patients, and therefore excellent signal
to noise ratio and contrast to noise ratio for detection of components of small vessel disease. The study will
examine two cohorts 1) a group of 30 older adults recruited through the Alzheimer's Disease Research Center
(ADRC) for developing an MRI to histopathology statistical model of SVD and 2) 60 older adults with late-life
depression who will undergo scanning at baseline and after 2 years. The longitudinal 7T MRI and SVD model
will be used to help characterize the small vessel changes associated with depression in older adults.
In summary, this study develops an emerging and timely technology (high-performance ultrahigh field
MRI) to study a critical pathophysiological process (cerebral small vessel disease) in a clinically relevant
population (Late-Life Depression). This project will further advance all of these three domains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis
-
批准号:10738869
-
项目类别:
-
资助金额:$143.41万
-
财政年份:2023
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10590719
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10161693
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Research Education Component
-
批准号:10410389
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2020
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10652258
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:10343792
-
项目类别:
-
资助金额:$73.76万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:9912701
-
项目类别:
-
资助金额:$73.35万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10202409
-
项目类别:
-
资助金额:$24.22万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:10549382
-
项目类别:
-
资助金额:$75.04万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease
-
批准号:9765902
-
项目类别:
-
资助金额:$76.32万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Bioengineering in Psychiatry Training Program
-
批准号:10397601
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2019
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:10506442
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:9405041
-
项目类别:
-
资助金额:$60.88万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:10084318
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)
-
批准号:9234742
-
项目类别:
-
资助金额:$59.13万
-
财政年份:2017
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
High Performance Imaging for Assessment of Small Vessel Disease in Older Adults with Depression
-
批准号:9196861
-
项目类别:
-
资助金额:$68.55万
-
财政年份:2016
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Resilience to Mobility Impairment: Neural Correlates and Protective Factors
-
批准号:9085177
-
项目类别:
-
资助金额:$13.62万
-
财政年份:2015
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Ultra-high-field neuroimaging in elderly after a two-year exercise intervention
-
批准号:8910602
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2014
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Ultra-high-field neuroimaging in elderly after a two-year exercise intervention
-
批准号:9084465
-
项目类别:
-
资助金额:$32.59万
-
财政年份:2014
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
Ultra-high-field neuroimaging in elderly after a two-year exercise intervention
-
批准号:8694257
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2014
-
负责人:HOWARD J AIZENSTEIN
-
依托单位:
海外基金